For­ma­tion Bio’s up to €545M li­cens­ing deal with Sanofi; Ot­su­ka, Har­bour Bio­Med team up

Plus, news about In­cyte, Caris­ma Ther­a­peu­tics, Idor­sia, Leap Ther­a­peu­tics, En­terome, Mer­ck, Forte Bio­sciences, En­zon and Viskase:

For­ma­tion Bio li­cens­es JAK/SYK in­hibitor to Sanofi: The start­up …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER